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The 2 main species of Cryptosporidium that infect
humans are Cryptosporidium hominis and  C. parvum.
Here, multilocus fragment analysis of 3 microsatellite loci
(ML1, ML2, and gp60) was used to subtype strains from
sporadic cases of cryptosporidiosis in Wales and northwest
England. Of 72 strains of C. parvum, 63 were typeable at
all 3 loci, forming 31 subtypes. These strains formed 3
broad clusters, representing 74.6%, 20.6%, and 4.8% of
typeable strains. Of 118 C. hominis strains, 106 were
typeable at all 3 loci, forming 9 subtypes; however, 90%
belonged to the same subtype. Analysis with epidemiolog-
ic data found an association between strains from case-
patients who reported contact with farm animals and
individual C. parvum microsatellite alleles. The strongest
association was with ML1; all strains from case-patients
that reported farm animal contact had the same allele
(ML1–242). Microsatellite typing of C. parvum provides
valuable additional information on the epidemiology of this
pathogen.
C
ryptosporidium species are intestinal parasites that
infect a variety of animals; Cryptosporidium hominis
(synonym: Cryptosporidium parvum genotype 1) and C.
parvum (synonym: C. parvum genotype 2) are the 2 most
commonly identified species that cause disease (cryp-
tosporidiosis) in humans (1,2). The main symptom of cryp-
tosporidiosis is diarrhea, which may be accompanied by
dehydration, weight loss, abdominal pain, fever, nausea,
and vomiting (3). In England and Wales, ≈5,000 cases are
reported annually (4). Disease, although lasting for up to 2
weeks, is usually self-limiting in immunocompetent per-
sons but may be chronic and more severe in immunocom-
promised patients (5). Furthermore, C. hominis is associat-
ed with increased risk of postinfection symptoms (6).
C. hominis primarily infects humans but has recently
been reported to infect a dugong and a lamb, and other ani-
mals have been infected experimentally (7). Rare occur-
rences of low-level natural infection of cattle by
C. hominis have also been reported (8). By contrast,
C. parvum naturally infects several animal species that
serve as reservoirs for zoonotic infection, including cattle,
sheep, goats, and deer (7).
Several methods have been described by different
research groups to investigate intraspecies variation with-
in the genus Cryptosporidium, including microsatellite
sequence analysis (9–12), minisatellite and microsatellite
PCR fragment length analysis (13,14), single-strand con-
formation polymorphism analysis (15), gp60 sequence
analysis (16,17), and telomere sequence analysis (18,19).
A recent study that used minisatellite and microsatellite
fragment analysis identified some C. parvum clones that
may not be zoonotic (13,14); this study compared isolates
from humans and bovines in a single Scottish county.
However, no epidemiologic data were presented on case-
patients. In the study described here, we investigated the
subtypes of C. parvum and C. hominis and tested the asso-
ciation of subtypes with known epidemiologic factors.
Materials and Methods
Strains
The strains included in this analysis were collected
during the case-control study of human cryptosporidiosis
in Wales and northwest England (20). This study is to date
the only case control-study of risk factors for cryp-
tosporidiosis with species identification of infecting
strains. Some 427 case-patients and controls were
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Kingdom surveyed by mail questionnaire. The key findings were
that travel abroad and changing diapers of children <5
years of age were associated with risk for C. hominis infec-
tions. For C. parvum, touching farm animals was associat-
ed with illness but eating raw vegetables and tomatoes was
strongly negatively associated with illness.
As part of that study, clinical laboratories were
encouraged to send fecal samples positive for
Cryptosporidium by microscopy to the UK Crypto-
sporidium Reference Unit in Swansea. Confirmation that
samples were positive by microscopy was performed when
required by using a modified Ziehl-Neelsen method as
described by Casemore et al. (21). To extract Crypto-
sporidium DNA from microscopy-positive feces, oocysts
were first separated from fecal matter by saturated-salt-
solution centrifugation as described by Elwin et al. (22).
The oocyst suspension was then incubated at 100°C for 60
min, digested with proteinase K and lysis buffer, and puri-
fied by using QIAamp DNA Mini Kit spin columns (QIA-
GEN Ltd, Crawly, UK) as described previously (2). DNA
was stored at –20°C before species determination and sub-
typing, when appropriate.
Identification of Species or Genotype by
PCR–Restriction Fragment Length Polymorphism
Analysis (PCR-RFLP)
Cryptosporidium sp. was determined by PCR-RFLP
analysis of the Cryptosporidium oocyst wall protein
(COWP) and small subunit (SSU) rRNA genes using
methods based on those described by Spano et al. (23) and
Xiao et al. (24), respectively. For PCR-RFLP analysis of
the COWPgene, PCR was carried out by using the forward
primer 5′-GTAGATAATGGAAGAGATTGTG-3′ and
reverse primer 5′-GGACTGAAATACAGGCATTAT
CTTG-3′ to produce an amplicon of ≈550 bp. The PCR
products were digested by using the restriction enzyme
RsaI to differentiate between most Cryptosporidium spp.
For nested PCR-RFLP analysis of the SSU rRNA
gene, the primary PCR produced fragments of ≈1,325 bp
by using the forward primer 5′-TTCTAGAGCTAATA
CATGCG-3′ and the reverse primer 5′-CCCATTTC
CTTCGAAACAGGA-3′. The secondary PCR, which pro-
duced fragments of ≈830 bp, used the forward primer 5′-
GGAAGGGTTGTATTTATTAGATAAAG-3′ and the
reverse primer 5′-AAGGAGTAAGGAACAACCTCCA-
3′. The products of the secondary PCR were digested with
SspI and VspI. Digested fragments from SSU rRNA and
COWP genes were separated by electrophoresis on 3%
agarose gels, visualized by SYBR Green I (Sigma,
Gillingham, UK) staining, and images were recorded with
a digital imaging system (Alpha Imager, Kodak, Hemel
Hempstead, UK).
Confirmation of Species or Genotype by SSU rRNA
Gene Sequence Analysis
After PCR-RFLP analysis, unusual species and equiv-
ocal samples were confirmed by amplifying a fragment of
the SSU rRNA gene and DNA sequencing in both direc-
tions. Briefly, amplicons of ≈830 bp were produced from
each sample by using the nested primer set described above
(23), and an ≈298-bp fragment was sequenced (Genetic
Research Instrumentation, Braintree, UK) by using the for-
ward primer 5′-AGTGACAAGAAATAACA ATACAGG-
3′ and the reverse primer 5′-CCTGCTTTAAGCACTCT
AATTTTC-3′ (25). The forward and reverse sequences of
these fragments were then aligned and analyzed with a
CEQ 8000 Genetic Analysis System (Beckman Coulter,
High Wycombe, UK) to obtain a consensus sequence. This
sequence was then compared with all GenBank, EMBL,
DDBJ, and PDB sequences by using the National Center
for Biotechnology Information BLASTN tool (available
from www.ncbi.nlm.nih.gov/BLAST/).
Analysis of C. hominis and C. parvum Subtypes
Subtypes were identified by using a multilocus frag-
ment-size–analysis approach to target 3 microsatellite
markers (ML1, ML2, and gp60 [synonymous with gp15])
as previously described (26). The ML1 fragment was
amplified by using the forward primer 5′-CTAAAAATG
GTGGAGAATATTC-3′ and the reverse primer 5′-CAACA
AAATCTATATCCTC-3′ (10,11). The ML2 fragment was
amplified by using the forward primer 5′-CAATG
TAAGTTTACTTATGATTAT-3′ and the reverse primer 5′-
CGACTATAAAGATGAGAGAAG-3′ (11). The gp60
fragment was amplified by using the forward primer 5′-
GCCGTTCCACTCAGAGGAAC-3′ and the reverse
primer 5′-CCACATTACAAATGAAGTGCCGC-3′ (13).
Reverse primers were supplied that were labeled with
Beckman Coulter WellRED D3 dye (Proligo,  Paris,
France). The 50-µL PCR mixture for each primer set con-
tained PCR buffer (QIAGEN Ltd), 2.5 mmol/L of MgCl2,
200 µmol/Lof each dNTP, 500 nmol/Lof each primer,   2.5
U of HotStar Taq DNA polymerase (QIAGEN Ltd), and 5
µL of template DNA. The cycling conditions for each PCR
were an initial denaturing step of 15 min at 95°C, then 40
cycles of 95°C for 50 s, 50°C (60°C for gp60) for 50 s, and
72°C for 60 s before a final extension of 10 min at 72°C.
The fragment sizes of amplified products were then ana-
lyzed with a CEQ 8000 Genetic Analysis System
(Beckman Coulter). Allele nomenclature was based on the
median fragment size of each natural group rounded to the
nearest probable base pair number. The combined results of
fragment-size analysis at all 3 markers were used to create
a multilocus fragment type for subtypes within C. parvum
and C. hominis as described elsewhere (26,27).
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Data analysis was carried out by using SPSS 12.0
(SPSS Inc., Chicago, IL, USA). Subclusters were identi-
fied by using the SPSS clustering algorithm, a hierarchical
algorithm that clusters strains and other clusters together
on the basis of their similarity.
χ2 tests (or Fisher exact test when data were sparse)
were used to identify significant trends between C. parvum
cluster 1 and C. parvum clusters 2 and 3 combined, with
epidemiologic parameters. A final multivariable model
was derived by using logistic regression as previously
described (20) and including all the different strains of C.
parvum; the model was recalculated including only the
strains that possessed the ML1–242 allele.
The Hunter-Gaston index of discriminatory power
was calculated by using StatsDirect (28). This index was
proposed as a measure of the discriminatory power of
microbial typing schemes. By using the typing scheme
under investigation, it calculates the probability of ran-
domly picking 2 unrelated strains and finding them to be
different.
Results
A total of 190 sporadic strains of Cryptosporidium
were included in this analysis: 118 were C. hominis, of
which 106 were typeable at all 3 microsatellite loci; 72
were C. parvum, of which 63 were typeable at all 3 loci.
The distribution of these types is shown in Table 1.
Of the 106 strains of C. hominis typeable at all 3 loci,
95 (90%) were indistinguishable at all 3 loci, having the
ML1 allele 233 (ML1–233), ML2–180, and gp60–371.
This lack of diversity of C. hominis as demonstrated by
these 3 markers did not allow further analysis.
Much greater diversity in allele size at all 3
microsatellite loci was displayed by C. parvum than by C.
hominis. The discriminatory power of the 3-loci typing
method for C. parvum using the Hunter-Gaston index of
discriminatory power was 0.957 (95% confidence interval
[CI] 0.937–0.977). For C. hominis, the discriminatory
power was 0.197 (95% CI 0.096–0.298).
The online Appendix Figure (available from www.
cdc.gov/ncidod/EID/13/1/82-appG.htm) shows a 3-dimen-
sional scatterplot of the strains of C. parvum. Considerable
variation can be seen in microsatellite length, and 3 broad
subclusters are identifiable. Strains belonging to the 2
smaller clusters had the same ML1–227 allele, whereas all
strains belonging to the larger cluster had the ML1–242
allele.
We further looked at the association between polymor-
phisms at the 3 loci and reported case-patient contact with
animals. For this analysis, all strains were included,
whether or not they were typeable at all 3 loci. Significantly
more persons with strains with ML1–242 (22/52, 43%) had
touched or handled farm animals than those with ML1–227
strains (0/14, 0%) (Mann-Whitney U test, p = 0.000 (Figure
1). Similarly, at ML2, significantly more strains with alle-
les between 223 and 237 (42%, 22/52) were from case-
patients who had touched or handled farm animals than
were strains with alleles 193 and 197 (0%, 0/13) (Mann-
Whitney U test, p = 0.000) (Figure 2). Alleles of gp60
(Figure 3) varied from 311 to 371 bp and peaked at 340 to
341 bp. Case-patients who had contact with farm animals
yielded significantly greater product sizes at this locus than
those who reported no animal contact before onset of ill-
ness (Mann-Whitney U test, p = 0.003).
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polymorphism and contact with animals, the final logistic
regression model for C. parvum presented in our earlier
article (20) was re-run but included only those strains with
the 242-bp allele. The positive association with farm ani-
mals and the negative associations with eating raw vegeta-
bles all are stronger in the model with just ML1–242 allele
strains than in the model containing all C. parvum strains
(Table 2).
Each typeable strain was also categorized by local
environment, based on postal code of patient’s residence.
These categories were urban, town or town fringe, village,
and hamlet or isolated dwelling. The attack rates per
100,000 population for each of the 2 ML1 types of C.
parvum are shown in Table 3. The incidence of ML1–242
strains increased as the home environment became
increasingly rural, whereas ML1–227 strains were largely
restricted to urban and town environments (Mann-Whitney
U test, p = 0.005).
Discussion
At these 3 microsatellite loci, much greater genetic
diversity was detected among C. parvum strains than
among C. hominis strains. For C. parvum the 3 loci were
highly discriminatory (Hunter-Gaston index 0.957), but for
C. hominis, they were poorly discriminatory (0.197).
These 3 loci by themselves are unlikely to be sufficient for
subtyping C. hominis but are adequate for subtyping C.
parvum.
Using all 3 loci, the typeability for C. hominis was
90% and for C. parvum 87.5%. The presence of nonty-
peable strains in any one of the 3 single loci reduced the
overall typeability and therefore discriminatory power of
the typing method. However, strains that did not type at
every locus could still be compared. For example, 70
(96%) strains of C. parvum were typed at the ML1 locus,
which improved the power of analyses using just this
locus. We are unable to say whether nontyping at a partic-
ular locus was because of an unusual allele or because of
the sensitivity of the method.
The low diversity of C. hominis is to be expected
because it is a species-specific parasite. Hunter and Fraser
(29) noted that species adapted to single host species were
likely to be less genetically diverse than those with a wider
host range, as predicted by the theory of adaptive polymor-
phism. Greater genetic variation was also found among C.
parvum (type 2) than C. hominis (type 1) isolates in a pre-
vious study that used minisatellite and microsatellite loci
(13). This apparently low genetic diversity among strains
of C. hominis might make it difficult to develop discrimi-
natory and reproducible typing methods for C. hominis.
However, recent investigation of isolates from global
sources at multiple minisatellite and microsatellite loci
showed increased polymorphism, particularly over many
minisatellite loci (30). On the other hand, the use of only 3
loci gives good discriminatory power for C. parvum.
Using just 3 microsatellite loci, we have shown that 3
major groupings of C. parvum can be found, which sup-
ports the similar findings of Mallon et al. (13), who used 7
loci. These researchers reported that the largest cluster
contained strains isolated from both humans and animals,
while the 2 smaller clusters contained strains isolated only
from humans. In our study, all strains isolated from per-
sons reporting contact with animals came from cluster 1,
which supports the suggestion of 2 clones of human-adapt-
ed strains of C. parvum.
The most intriguing finding was that of an association
between strains of C. parvum that may be human-adapted
or zoonotic and particular alleles of the microsatellites.
While this association included all 3 loci, the strongest
association was with alleles at the ML1 locus. This obser-
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Figure 1. Product size at microsatellite locus ML1 with number of
Cryptosporidium parvum case-patients who touched or handled
farm animals before onset of illness. 
Figure 2. Product size at microsatellite locus ML2 with number of
Cryptosporidium parvum case-patients who touched or handled
farm animals before onset of illness.vation was even more dramatic, given that only 2 alleles
were found at this locus. None of the case-patients whose
strains yielded ML1–227 reported contact with farm ani-
mals, while 43% of those whose strains yielded ML1–242
reported such contact. This finding is strengthened by the
observation that most of the case-patients yielding cluster
2 or 3 strains were more likely to live in urban areas where
the possibilities for animal contact are lower than for those
yielding cluster 1 strains. In a related study, all 28 strains
isolated from animals were ML1–242, which further sup-
ports this hypothesis (27,31).
Although the ML2 locus is more variable than the
ML1 locus, the 2 loci correlate very closely. This linkage
disequilibrium between the 2 loci has already been noted
by other researchers (11), although we must emphasize
that our results differ from those of Cacciò et al. (11), who
detected 3 alleles at the ML1 locus (ML1–238, ML1–226,
and ML1–220). By sequencing PCR products, these
authors also found all 3 alleles in isolates from animals.
These discrepancies are not likely to be due to the differ-
ent methods used for sizing of PCR fragments.
We cannot yet conclude that our findings indicate
human-adapted strains of C. parvum exist or if all strains
are potentially zoonotic. ML1–227 strains do not appear to
be zoonotic in the United Kingdom but have been identi-
fied as such by other workers in Italy (11), for example. If
such strains are zoonotic in other countries, they likely
would have spread into the UK human population through
imported foods or during foreign travel and subsequently
spread among humans. However, they may not have yet
made the transition to UK animals.
Microsatellite fragment analysis of C. parvum would
appear to provide a discriminatory and rapid means of dis-
tinguishing strains. This technique would be useful in out-
break settings to determine whether outbreaks were due to
single or multiple strains and, if the former, may indicate
the source of contamination. The microsatellites used in
this work would not be discriminatory enough for routine
use for C. hominis, although others may prove to be of
more value.
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Figure 3. Product size at microsatellite locus gp60 with number of
Cryptosporidium parvum case-patients who touched or handled
farm animals before onset of illness.Acknowledgments
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